Skip to main content

Table 5 Efficacy of remdesivir in SARS-CoV-2 animal models

From: The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance

Author

Model

L/M dose

Route

Vial burden

Clinical improvement

Pruijssers et al. 2020

Mousea

25 mg/kgb

sc

> 99 ↓

↑↑↑

Williamson et al. 2020

R. macaques

10/5 mg/kg/d

iv

100 x ↓

↑↑↑↑

Ye et al. 2021

Hamster

15 mg/kg

ip

> 80% ↓

↑↑↑↑

Yuan et al. 2021

Hamster

15 mg/kg

ip

~ 20% ↓

↑↑

  1. a Ces1c knockout; b Twice a day; R rhesus, sc subcutaneous injection, iv intravenous injection, ip intraperitoneal injection